[go: up one dir, main page]

DK0701565T3 - Nye prednisolonderivater - Google Patents

Nye prednisolonderivater

Info

Publication number
DK0701565T3
DK0701565T3 DK94913100T DK94913100T DK0701565T3 DK 0701565 T3 DK0701565 T3 DK 0701565T3 DK 94913100 T DK94913100 T DK 94913100T DK 94913100 T DK94913100 T DK 94913100T DK 0701565 T3 DK0701565 T3 DK 0701565T3
Authority
DK
Denmark
Prior art keywords
pct
new
prednisolone derivatives
sec
date
Prior art date
Application number
DK94913100T
Other languages
English (en)
Inventor
Beate Gutterer
Hermann Amschler
Dieter Flockerzi
Richard Riedel
Stefan Postius
Michael Stoeck
Rolf Beume
Karl Zech
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Application granted granted Critical
Publication of DK0701565T3 publication Critical patent/DK0701565T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK94913100T 1993-04-02 1994-03-31 Nye prednisolonderivater DK0701565T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH102393 1993-04-02
PCT/EP1994/001015 WO1994022899A1 (de) 1993-04-02 1994-03-31 Neue prednisolonderivate

Publications (1)

Publication Number Publication Date
DK0701565T3 true DK0701565T3 (da) 1999-07-12

Family

ID=4200650

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94913100T DK0701565T3 (da) 1993-04-02 1994-03-31 Nye prednisolonderivater

Country Status (21)

Country Link
US (1) US5733901A (da)
EP (1) EP0701565B1 (da)
JP (1) JP3333210B2 (da)
KR (1) KR100330941B1 (da)
CN (1) CN1062869C (da)
AT (1) ATE172739T1 (da)
AU (1) AU683463B2 (da)
BG (1) BG62491B1 (da)
CZ (1) CZ287877B6 (da)
DE (1) DE59407183D1 (da)
DK (1) DK0701565T3 (da)
ES (1) ES2124884T3 (da)
FI (1) FI113543B (da)
HU (1) HU220868B1 (da)
NO (1) NO305990B1 (da)
NZ (1) NZ265054A (da)
PL (1) PL179489B1 (da)
RU (1) RU2132854C1 (da)
SK (1) SK281226B6 (da)
UA (1) UA45311C2 (da)
WO (1) WO1994022899A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
HU228432B1 (hu) * 2000-11-10 2013-03-28 Nycomed Gmbh Eljárás 16,17-(ciklohexilmetilén)-bisz(oxi)-11,21-dihidroxi-pregna-1,4-dién-3,20-dion elõállítására transz-ketálozással
DE10055820C1 (de) * 2000-11-10 2002-07-25 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung eines Glucocorticoids
ATE472329T1 (de) * 2002-08-30 2010-07-15 Nycomed Gmbh Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis
US7879833B2 (en) * 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
US8435497B2 (en) * 2003-06-13 2013-05-07 Takeda Gmbh Formoterol of and ciclesonide combination
AU2004271743B2 (en) * 2003-09-15 2010-06-10 Covis Pharma B.V. Use of ciclesonide for the treatment of inflammatory bowel diseases
JP5618452B2 (ja) * 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングTakeda GmbH 呼吸器疾患の治療のためのシクレソニドの使用
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
US20080027034A1 (en) * 2004-09-10 2008-01-31 Shah Tushar P Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof
CN100345864C (zh) * 2004-10-29 2007-10-31 天津药业研究院有限公司 一种治疗呼吸道疾病的甾体药物的制备方法及其中间体
RU2008100237A (ru) * 2005-06-14 2009-07-20 Джилид Сайэнс, Инк. (US) ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
EP2392584A1 (en) * 2006-09-19 2011-12-07 Cipla Limited Crystalline Ciclesonide Methanol Solvate Form C
WO2009112557A2 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) * 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
EP2407476B1 (en) 2009-03-09 2014-05-07 Mikasa Seiyaku Co,. Ltd. Steroid compound
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
US9109005B2 (en) * 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
CN103421075B (zh) * 2012-05-16 2017-07-28 上海特化医药科技有限公司 孕烷衍生物16,17‑缩醛(酮)的制备方法
MA51586A (fr) 2016-06-02 2019-04-10 Abbvie Inc Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci
PE20201286A1 (es) 2017-12-01 2020-11-24 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados de este

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
SE378109B (da) 1972-05-19 1975-08-18 Bofors Ab
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.

Also Published As

Publication number Publication date
HU220868B1 (en) 2002-06-29
FI954579L (fi) 1995-09-27
CN1120339A (zh) 1996-04-10
US5733901A (en) 1998-03-31
FI113543B (fi) 2004-05-14
CZ252995A3 (en) 1996-01-17
ES2124884T3 (es) 1999-02-16
CN1062869C (zh) 2001-03-07
KR100330941B1 (ko) 2002-10-12
HUT72594A (en) 1996-05-28
NO953861D0 (no) 1995-09-29
AU683463B2 (en) 1997-11-13
SK122395A3 (en) 1996-01-10
AU6538194A (en) 1994-10-24
ATE172739T1 (de) 1998-11-15
SK281226B6 (sk) 2001-01-18
HU9502819D0 (en) 1995-11-28
NZ265054A (en) 1997-08-22
FI954579A0 (fi) 1995-09-27
EP0701565B1 (de) 1998-10-28
CZ287877B6 (cs) 2001-03-14
BG62491B1 (bg) 1999-12-30
WO1994022899A1 (de) 1994-10-13
NO305990B1 (no) 1999-08-30
PL179489B1 (pl) 2000-09-29
EP0701565A1 (de) 1996-03-20
BG100032A (bg) 1996-05-31
PL311474A1 (en) 1996-02-19
JP3333210B2 (ja) 2002-10-15
RU2132854C1 (ru) 1999-07-10
DE59407183D1 (de) 1998-12-03
UA45311C2 (uk) 2002-04-15
JPH08508278A (ja) 1996-09-03
NO953861L (no) 1995-09-29

Similar Documents

Publication Publication Date Title
DK0701565T3 (da) Nye prednisolonderivater
TW285667B (da)
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
PL310171A1 (en) Novel imidazopyridines
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
TW261614B (da)
TW251283B (da)
AU6675794A (en) Benzo(F)quinoxalindione derivatives, their preparation and their use in drugs
DK0731801T3 (da) Substituerede aminoaylkylaminopyridiner
NO952926D0 (no) Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
CA2159627A1 (en) Novel prednisolone derivatives

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment